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Abstract
Background As many patients with gallstone disease do not benefit from cholecystectomy, preoperative recognition of such
high-risk patients is important. The aim of the study is to identify predictors of persisting symptoms at 6 months after
cholecystectomy for patients with different preoperative symptomatology.
Method Participants in this prospective study were consecutive patients (n=172), age 18–65 years, with symptomatic
cholelithiasis, undergoing a laparoscopic cholecystectomy. Predictors were identified using uni- and multivariate regression
analyses.
Results At 6 months postcholecystectomy, patients with only preoperative biliary symptoms were most often free of
symptoms (62.5%). Patients with only dyspeptic symptoms most often reported persistence of preexisting symptoms
(63.2%). Preoperative non-specific symptoms predicted the report of postoperative biliary and/or dyspeptic symptoms
(OR=4.5–6.1). Persistence of preexisting pattern of symptoms was predicted by the use of psychotropic medication
(OR=5.3) and dyspeptic symptoms (OR=4.5). Postoperative biliary symptoms were predicted by High Trait Anxiety
(HTA) (OR=10.6).
Conclusion Surgeons should take account of individual risks of patients in the management of cholelithiasis. Instead of
cholecystectomy, expectative management should be the first choice in patients with non-specific symptoms, with dyspeptic
symptoms only, with HTA and in patients using psychotropic medication.
Keywords Cholecystectomy.Cholelithiasis.
Outcome assessment.Risk assessment.Surgery
Introduction
Gallstone disease (cholelithiasis) is a common condition that
affects 5% to 22% of the people in Western countries.
1,2
Most patients are unaware of their condition
3 and only
10–30% of these patients develop clinical symptoms,
4–7 such
as classical biliary colics or other gastrointestinal symptoms.
Laparoscopic cholecystectomy is the golden standard in the
management of uncomplicated symptomatic cholelithiasis.
As cholecystectomy entails the risk of peri- and early
postoperative complications (0.2–9.4%)
5,8 and a substantial
number of patients (40.4%) report negative outcome after
cholecystectomy,
9,10 critical consideration of pros and cons
of cholecystectomy is required. Identification of potential
predictors of negative outcomes is essential for decision
making in elective cholecystectomy.
Clinical characteristics, such as preoperative dyspeptic
symptoms,
11–13 medication use,
10 age,
14,15 characteristics
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DOI 10.1007/s11605-010-1219-6of preoperative pain and symptoms
12,13,15,16 have been
identified as associates of long- and short-term postchole-
cystectomy outcomes. However, the comparability of results
is hampered by different criteria for inclusion, moments of
follow-up, definitions and operationalisations of variables
and outcomes. Besides ‘hard’, clinical characteristics, ‘soft’
predictors such as self-rated health status,
13 personality
traits,
12,17–19 and other psychological variables
20 have been
identified as predictors of negative outcomes as well. Despite
the fact that the symptomatology of cholelithiasis is
ambiguous and only the minority of patients report classical
biliary colics,
5,21 preoperative symptoms (in combination
with ultrasound examination) are used as a reference point
for diagnosis and indication of cholecystectomy in clinical
practice. Therefore, in the current study we aimed at the
identification of predictors of postoperative symptoms at
6 months postcholecystectomy for patients with different
preoperative symptomatology.
Methods
Patients
Patients for the current study were recruited from the
Department of Surgery of the St. Elisabeth Hospital in
Tilburg, the Netherlands. Consecutive patients (18–65 years)
with diagnosed symptomatic cholelithiasis, awaiting an
elective laparoscopic cholecystectomy who visited the
hospital between March 2006 and January 2008, were
eligible for the study. Exclusion criteria were: patients with
ASA III or IV, undergoing an emergency procedure or
intended open cholecystectomy, insufficient knowledge of
the Dutch language, choledocholithiasis, cholangitis, known
pregnancy, known liver-cirrhosis, history of abdominal
malignancy, previous upper abdominal surgery (precluding
laparoscopic approach) and psychiatric diseases. All patients
underwent a standard surgical and anaesthetic procedure.
The protocol of the study was approved by the local ethics
committee.
Procedure
Preoperatively, participation was asked during the patients'
first surgical consultation at the outpatient clinic. The
surgeon introduced the study, whereas subsequently nurses
informed patients about the research procedures. Patients
received the first set of questionnaires, which also
contained written information about the study, and signed
informed consent. Medical history and comorbidities
were obtained from medical records. Patients completed
and returned the first questionnaires before admission for
cholecystectomy. If necessary, patients received a
reminder telephone call to return the questionnaires 3 to
5 days before the operation. Patients who returned the
questionnaires after admission were excluded from the
study. At 6 months after cholecystectomy, patients
received the same questionnaire which could be returned
in a prepaid envelope. If needed, patients were contacted
by telephone twice, usually 2 and 4 weeks after sending
the questionnaires. Patients returning their second ques-
tionnaire >9 months after surgery were considered as
non-responders.
Questionnaires
The demographic questionnaire was completed preopera-
tively and asked about sex, age, marital status, educational
level and work. Preoperatively and at 6 months post-
cholecystectomy, patients completed a symptom checklist
based on information from focus groups of gallstone
patients.
22 Patients should tick off whether they experi-
enced biliary symptoms (upper abdominal pain, nausea,
vomiting), dyspeptic symptoms (bad taste, heartburn,
under abdominal pain, diarrhoea and flatulence) and non-
specific symptoms (general malaise, fatigue, weight
change, decrease in sexual functioning and health com-
plaints not mentioned in the predefined checklist) in the
past week. Symptoms were categorised according to a
study of Weinert et al.,
13 that was based on the Minnesota
Clinical Comparative Assessment Project database.
23
Furthermore, patients indicated the nature, severity, dura-
tion and frequency of pain during preoperative biliary
attacks on a 100-mm visual analogue scale and on three
multiple choice items. All included patients had experi-
enced biliary or dyspeptic symptoms in medical history.
After surgery, surgical reports were checked for the
presence of gallstones/sludge and conversion to open
surgery.
Patients completed the trait scale of the State-Trait
Anxiety Inventory (STAI) preoperatively. The STAI-trait
exists of 20 items with a 4-item Likert scale reflecting the
extent of anxiety patients generally feel. The STAI-Trait
Anxiety measure has good 3 months test–retest reliability
(r=.75) and internal consistency (Cronbach's α=.84–.92).
24
Patients scoring the 80th percentile or higher were indicated
as patients with ‘High Trait Anxiety’ (HTA), whereas
patients with a score below the 80 th percentile were
indicated as patients with ‘Non-High Trait Anxiety’.
Statistical Procedure
Differences between groups of patients with preoperative
biliary, dyspeptic or a combination of these symptoms were
calculated using Chi-square tests for dichotomous and
ordinal variables and one-way ANOVA between subjects
1272 J Gastrointest Surg (2010) 14:1271–1279for continuous variables. Friedman's tests were used to
calculate an overall difference in symptom report between
the preoperative measurement and the measurement and
6 months. Changes in symptom report over a 6-month time
were obtained using Wilcoxon's signed-rank tests (for
ordinal variables) and McNemar's tests (for dichotomous
variables). Significance was obtained from Chi-square tests
and, if necessary, Binominal tests.
Persistence and emergence rates were obtained for ‘any
symptom’. Persistence was defined as patients reporting the
same symptom preoperatively and at 6 months. An overall
score was calculated form biliary, dyspeptic, and biliary/
dyspeptic symptoms. Emergence was defined as patients
who did not report a specific symptom preoperatively, but
who reported the symptom at 6 months. Again an overall
score was obtained for biliary, dyspeptic, and biliary/
dyspeptic symptoms.
Univariate logistic and multinominal regression analyses,
taking ‘symptom free’ as reference group, were performed to
identify predictors of postoperative symptoms at 6 months.
These analyses were used for dichotomous and categorial
outcomes, respectively. Significant predictors were selected
and inserted in multivariate logistic or multinominal regres-
sion analysis (Backward procedure, Method Likelihood
Ratio) to identify independent predictors of postoperative
symptom report. In multinominal regression analysis, the
reference category was ‘symptom free’.Ap value<.05
indicated statistical significance. Statistical analyses were
performed using SPSS version 16.0.
Results
A flow-chart of the population under study is shown in
Fig. 1. In total, 253 patients received the first set of
questionnaires, of which 172 patients returned their ques-
tionnaires at 6 months after cholecystectomy (response rate
68.0%). Clinical and demographic patient characteristics are
shown in Table 1. The majority of patients (61.9%) reported
both biliary and dyspeptic symptoms (Table 2). Moreover,
24.5% of the patients only reported biliary symptoms, and
13.6% of the patients only reported dyspeptic symptoms. In
this study, groups of patients were based on the report of
preoperative biliary symptoms (group 1), dyspeptic symp-
toms (group 2) or both (group 3). These groups did not differ
on any clinical or demographic characteristics.
Six Months Benefit of Cholecystectomy
At 6 months after the operation, the majority of patients
had started their normal daily activities (95.5%). Of the
patients who had paid work (n=117), 99.1% had returned
Meeting criteria for inclusion n = 307
Missed at the outpatient clinic n = 10
Expectative management n = 28
Approached to participate n = 269
Refused n = 16
Received preoperative questionnaire n = 253
Not returned preoperative questionnaire n = 35
Returned preoperative questionnaire n = 218
Ended participation within 6 months n = 11
Received questionnaire at 6 months n = 207
Not returned the questionnaire  n = 35
Population under study n = 172
Fig. 1 Flow-chart of the
population.
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work.
Six months after cholecystectomy, 47.8% of the patients
were free of symptoms (see Fig. 2), whereas persistence
and emergence of any symptom was reported by 17.9% and
34.0% the patients, respectively. At 6 months, a substantial
group of patients still reported specific postoperative health
complaints, such as wound pain (7.2%), shoulder pain
(10.1%) and pain in the upper right abdomen (13.7%) at
follow-up. Over 6 months time, the number of patients with
biliary symptoms only and a combination of biliary and
dyspeptic symptoms decreased from 24.5% to 3.1% and
from 61.9% to 14.3%, respectively. However, the number of
patients that reported dyspeptic symptoms increased from
13.6% preoperatively to 34.8% at 6 months postoperatively
(see Fig. 2).
Patient groups were compared with regard to postoper-
ative symptomatic outcome at six months. The overall
symptomatic outcome of patients in group 2 differed
significantly from the outcome of the other patient groups
(χ
2=8.30, p=.040). The three patient groups differed
significantly regarding the report of any postoperative
symptom (biliary or dyspeptic) (χ
2=6.29, p=.043). At
6 months, postoperative symptoms were reported by 68.4%
of the patients in group 2, whereas postoperative symptoms
were reported by 37.5% and 60.2% of the patients in group
1 and 3, respectively. Group 3 (n=53) differed significantly
from the other two groups.
Furthermore, the groups differed significantly with
respect to the persistence of the same pattern of preoper-
0
20
40
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80
100
Biliary Dyspeptic Biliary and 
dyspeptic
Symptom free
Symptoms
%
Preoperatively
At six months
p  < .001*
p < .001*
p < .001*
p < .001*
Fig. 2 Report of symptoms preoperatively and at 6 months post-
cholecystectomy.
Table 1 Demographic and Clinical Characteristics (n=172)
Demographic characteristics
Female patients (%) 76.2
Age (M±SD) 47.51±11.33
Highest level of education
Lower or vocational education (%) 17.1
Secondary education (%) 49.4
Higher education (%) 6.4
Higher professional education or university (%) 27.1
Working under payment (%) 68.8
Marital status
Single (%) 4.1
Widowed or divorced (%) 5.9
Married or cohabitant (%) 90.0
Medical characteristics
Self-reported medication use
Analgetics (%) 36.8
Psychotropic medication (%) 9.9
Other medication (%) 49.7
Comorbidities
Coronary arterial disease (%) 18.0
Pneumonal disease (%) 5.8
Abdominal disease (%) 22.1
Kidney disease (%) 0.6
Urogenital disease (%) 8.1
Neurological disease (%) 9.9
Other comorbidities (%) 43.6
High trait anxiety (HTA) STAI-Trait ≥ P 80 (%) 20.1
Table 2 Preoperative Presentation of Cholelithiasis
Preoperative symptom report
Upper abdominal pain (%) 66.5
Nausea (%) 40.4
Vomiting (%) 56.1
Bad taste (%) 21.6
Heartburn (%) 27.5
Under abdominal pain (%) 20.5
Diarrhoea (%) 18.7
Flatulence (%) 36.8
Biliary symptoms
a only (%) 24.5
Dyspeptic symptoms
b only (%) 13.6
Biliary
a and dyspeptic
b symptoms (%) 61.9
Demonstrated stones or sludge (%) 91.9
Preoperative biliary attacks (M±SD) 5.2±7.2
Pain during biliary attacks
Pain in rest and movement (%) 94.3
Pain only in rest (%) 4.5
Pain only in movement (%) 1.2
Non-specific symptoms
c (%) 56.1
aBiliary symptoms, one or more of the following symptoms: upper
abdominal pain, nausea and vomiting
bDyspeptic symptoms, one or more of the following symptoms: bad taste,
heartburn, under abdominal pain, diarrhoea and flatulence
cNon-specific symptoms, one or more of the following symptoms: general
malaise (9.4%), fatigue (49.7%), weight change (2.9%), decreased sexual
functioning (10.5%) and other health complaints (12.3%)
1274 J Gastrointest Surg (2010) 14:1271–1279ative symptoms (χ
2=25.02, p<.001). Preexisting symp-
toms persisted most often in group 2 (63.2%), followed by
patients in group 3 and group 1 (18.2% and 3.1% of the
patients, respectively). Furthermore, preoperative groups
differed significantly regarding the development of new
symptoms postoperatively (χ
2=11.64, p=.003). Patients in
group 2 less often developed new symptoms after chole-
cystectomy than patient in the other groups (5.3% vs.
37.8% (χ
2=6.52, p=.011)). Patients in group 3 developed
symptoms of another category more often than patients in the
other groups (42.0% vs. 24.3% (χ
2=4.87, p=.027)). In fact,
4.5% and 37.5% of all patients in group 3, reported only
postoperative biliary or only postoperative dyspeptic symp-
toms, respectively, which implicates that preoperative biliary
symptoms subsided more often. Preoperative groups did not
differ with regard to the report of postoperative non-specific
symptoms.
Fig. 3 gives an overview of postoperative symptoms at
6 months for each group. Within each group, the number of
patients with the prominent preoperative symptom de-
creased. In group 1, a significant number of patients
developed a different pattern of complaints with dyspeptic
symptoms only (p=.005). Furthermore, over 6 months time,
the number of patients with non-specific symptoms
decreased within group 1 (p=.002) (Fig. 4). In contrast, in
group 2 the number of patients with non-specific symptoms
did not decrease. In group 3, a decrease of patients with
non-specific symptoms (p<.001) and a change to individual
biliary (p=.046) or dyspeptic symptoms (p<.001) was
observed at 6 months.
Predictors of 6 Months Outcome
Univariate logistic regression analyses were performed to
identify predictors of the report of (any) symptoms at
6 months. These results are shown in Table 3. Multivariate
regression analyses demonstrated that the postoperative
report of biliary and/or dyspeptic symptoms was predicted
by preoperative non-specific symptoms only (OR=3.06, p
=.003; 95% CI: 1.46–6.42). When groups of patients were
investigated separately, preoperative non-specific symp-
toms were the only predictor of any postoperative symptom
in group 1 (OR=6.11, p=.043; 95% CI: 1.06–35.35) and
group 2 (OR=4.53, p=.002; 95% CI: 1.77–11.60). No
predictors were identified for the report of any postopera-
tive symptom in group 3.
Predictors of persistence of existing symptoms were
investigated by univariate logistic regression analyses (see
Table 4). Multivariate logistic regression analysis demon-
strated that the use of psychotropic medication (OR=5.27,
p=.010; 95% CI: 1.50–18.55) and the preoperative report
of dyspeptic symptoms only (OR=16.69, p<.001; 95% CI:
4.59–60.68) were independent predictors of persisting
symptoms. Univariate and multivariate multinominal re-
gression analyses were performed to identify predictors of
postoperative biliary symptoms, dyspeptic symptoms and a
combination of biliary and dyspeptic symptoms. Results of
univariate regression analyses are shown in Table 5.
Entering these predictors simultaneously in a multivariate
multinominal regression analysis demonstrated that postop-
erative biliary symptoms were predicted by HTA only,
whereas postoperative dyspeptic symptoms were indepen-
dently predicted by preoperative dyspeptic and non-specific
symptoms. Non-specific symptoms and the use of psycho-
tropic medication predicted a postoperative course with
both biliary and dyspeptic symptoms (see Table 6).
Discussion
The results of cholecystectomy are disappointing for many
patients. Currently, the indication of an elective cholecys-
tectomy is such that many patients are operated without
critical consideration of individual expectations and risks.
At 6 months after cholecystectomy, merely 47.8% of the
patients were symptom free. In addition, 17.9% and 34.0%
of the patients reported persistence and emergence of new
symptoms, respectively. As it concerns a substantial number
Group 1 Group 2 Group 3
Preoperative groups
0
20
40
60
80
100
%
Preoperatively
Postoperatively
p = .002*
p < .001*
n.s.
Fig. 4 Report of non-specific symptoms over 6 months time.
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Group 1 Group 2 Group 3
Preoperative groups
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Free of symptoms
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Biliary and dyspeptic symptoms
Fig. 3 Report of symptoms at 6 months after cholecystectomy.
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increased risk of negative outcome is essential to optimise
the management of cholelithiasis. The present study demon-
strated that patients with preoperative dyspeptic symptoms
and patients using psychotropic medication are both at risk of
persistence of the preexisting pattern of health complaints
after cholecystectomy. Furthermore, patients with non-
specific symptoms and patients using psychotropic medica-
tion are at risk of the experience of biliary and/or dyspeptic
symptoms at 6 months. Patients with High Trait Anxiety
(HTA) have a ten times greater chance to experience
specifically postoperative biliary symptoms.
The current study investigated 6-months outcomes, as
the greatest improvement after cholecystectomy is seen
within this time period.
25 Overall, comparability of studies
focussing at approximately 6 months is limited,
10,13,15,26
because of differences in criteria for inclusion, designs,
classification, definition and operationalisation of outcomes
and variability in moments of follow-up. The percentage of
patients who are free of symptoms or report persisting
symptoms is comparable to results of other studies
focussing at 6 months.
10,13,15 The percentage of patients
developing new symptoms (34.0%) is higher than percen-
tages found in other studies (1.7–24.5%),
10,13,15,26 which
may be attributed to patients in group 3 who recover
partially and report only biliary or dyspeptic symptoms
after cholecystectomy.
In the current study, dyspeptic symptoms persisted more
often than biliary symptoms, which is in line with other
studies focussing at 6 months after cholecystectomy.
13,26
Differentiating between patient groups showed that patients
with only dyspeptic symptoms have the worst prognosis:
dyspeptic symptoms often tended to persist (63.2%) over
6 months time. Furthermore, in patients with a combined
symptom profile dyspeptic symptoms tend to persist
15 and
dyspeptic symptoms developed in 25% of the patients with
preoperative biliary symptoms. The latter findings support a
shift towards dyspeptic symptomatology at 6 months, as
mentioned in previous studies.
13,15 Reasons for this shift
may be related to preexistent gastrointestinal symptoms,
26
postoperative changes in duodenogastric reflux,
26 retained
stones or the formation of new gallstones,
27 or psychologic
variables such as HTA.
We found that patients with preoperative non-specific
symptoms are also at risk for any postoperative dyspeptic or
combined dyspeptic and biliary symptoms. The cause of these
non-specific symptoms is unclear; these symptoms may
coincide with biliary, dyspeptic or other health symptoms,
comorbid conditions or may contain a more subjective
component, influenced by psychological variables, such as
depressive symptomatology or personality. Weinert et al.
13
demonstrated that a subjective measure, namely self-rated
preoperative health status (SF 36), predicts outcomes at
6 months after cholecystectomy. However, the SF-36 consists
of items such as bodily pain which could be directly related to
biliary and dyspeptic symptoms. Therefore, we believe that a
parsimonious list of non-specific symptoms may be more
precise and better differentiates general symptoms from pure
Table 4 Univariate Predictors of Category of Postoperative Symptoms
Postoperative outcome Preoperative predictor OR 95% CI p value
Persistence of preoperative symptoms Dyspeptic symptoms only 12.71 4.40–36.70 <.001*
HTA 2.89 1.16–7.18 .023*
Number of non-specific symptoms 1.50 1.02–2.20 .041*
Psychotropic medication 5.51 1.90–15.96 .002*
Abdominal comorbidity 2.78 1.16–6.63 .022*
Significant results are reported only
*p<.050 indicated significanc
Preoperative characteristic OR 95% CI p value
Psychotropic medication 3.44 1.07–11.04 .038*
Non-specific symptoms 2.85 1.49–5.45 .002*
Combination of biliary and dyspeptic symptoms 2.10 1.12–3.94 .021*
HTA 2.89 1.23–6.79 .015*
Neurologic comorbidity 4.17 1.13–15.38 .032*
Table 3 Univariate Predictors
of Symptom Report at 6 Months
after Cholecystectomy
Significant results are reported
only
*p<.050 indicated significance
1276 J Gastrointest Surg (2010) 14:1271–1279biliary and dyspeptic symptoms. Although preliminary
results suggest that patients with non-specific symptoms
are at risk of negative postcholecystectomy outcomes,
further research needs to corroborate this finding and to
address the issue of subjectivity.
As persistent biliary symptoms are decisive for the
subjective perception of an unsuccessful procedure,
13
special attention needs to be paid to patients with HTA,
who are at risk to report persisting biliary symptoms at
6 months postcholecystectomy. So far, HTA has been
identified as a possible predictor of short-term postchole-
cystectomy outcomes.
19,28 Patients with HTA are predis-
posed to react with heightened anxiety to threatening
situations,
29 and may misinterpret a broad range of
gastrointestinal symptoms as being of biliary nature. Mis-
interpretations may be mediated by the fact that HTA
patients have higher pain sensitivity
30 and experience
gastrointestinal symptoms more often than other patients.
31
Otherwise, because of these characteristics, HTA patients
may be misdiagnosed as suffering from cholelithiasis and
abusively be subjected to cholecystectomy. Consequently
these patients will report persistence of preexisting symp-
toms. Possibly, psychosomatic mechanisms typically for
HTA patients, such as heightened activity of the sympa-
thetic nervous system,
32 production of higher levels of
noradrenaline,
33 may influence digestion, wound healing or
other bodily processes, which could be related to the
experience of biliary-type colics after removal of the
gallbladder. The role of HTA on long-term postcholecys-
tectomy outcomes and underlying mechanisms should be
further corroborated in future research.
The present study has several strengths, such as the
prospective design and the participation of consecutive
patients, which prevents a selection bias. In contrast to
other studies,
10,13,15,26 we used strict criteria for inclusion
of patients, such as symptomatic cholelithiasis, ASA I and
II, limited age differences, indicated for elective cholecys-
tectomy only, and used a big sample size (n=172). Follow-
up was limited to the period of 6 to 9 months postopera-
tively. This gives a homogenous sample, which enables
strong conclusions which are applicable to the field of
action where critical consideration matters most: elective
surgery. Another advantage of the study is the fact that the
clinical presentation of preoperative symptoms was used as
a basis for further investigation of predictors, which
enlarges the specificity of the predictors and enables the
clinical application of the results. The fact that we
dichotomised many variables (yes/no) enhances the conve-
nience to apply our findings directly in surgical practice.
Alternatively, it entails the risk over oversimplification of
our conclusions.
Other limitations of the study are the fact that we used
a self-constructed symptom checklist, instead of a stand-
ardised gastrointestinal questionnaire. We found it legit-
imate to use such a checklist, because we carefully based
our symptom checklist on information from focus
groups,
22 other symptom checklists, and clinical experi-
ence, and currently no disease specific symptom checklist
exists for cholelithiasis. The fact that we used broad
symptom categories, according to a leading article of
Weinert et al.,
13 increased the comparability to this study
in particular. However, as categorising symptoms into
Postoperative outcome Preoperative predictor OR 95% CI p Value
Biliary symptoms only HTA 12.19 1.76–84.30 .011*
Dyspeptic symptoms only Dyspeptic symptoms only 3.23 1.13–9.22 .029*
Neurologic comorbidity 4.72 1.22–18.35 .025*
Non-specific symptoms 2.11 1.04–4.26 .038*
Biliary and dyspeptic symptoms Psychotropic medication 9.73 2.59–36.53 .001*
HTA 5.00 1.59–15.74 .006*
Biliary and dyspeptic symptoms 2.74 1.01–7.42 .047*
Non-specific symptoms 8.01 2.19–29.33 .002*
Table 5 Univariate Predictors
of Category of Postoperative
Symptoms
Significant results are reported
only
*p<.050 indicated significance
Postoperative symptoms Preoperative predictor OR 95% CI p Value
Biliary symptoms HTA 10.64 1.24–90.96 .031*
Dyspeptic symptoms Dyspeptic symptoms only 5.69 1.50–21.63 .011*
Non-specific symptoms 2.50 1.10–5.64 .028*
Biliary and dyspeptic symptoms Non-specific symptoms 9.53 1.86–48.92 .007*
Use of psychotropic medication 8.01 1.75–36.75 .007*
Table 6 Independent Predictors
of Postoperative Symptoms
(Based on Multivariate Multi-
nominal Regression Analyses)
Significant results are reported
only
*p<.050 indicated significance
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comparability with other studies might be hampered.
Given the ambiguous clinical presentation of cholelithi-
asis and the vague diagnostic criteria, classification of
symptoms as being purely biliary or dyspeptic in nature
seems to be extremely difficult. Furthermore, it should be
noted that symptomatic outcome is not equivalent to
broad outcome measures such as health status or quality
of life, which can be easily assessed by standardised
questionnaires. We recommend that future studies should
investigate postcholecystectomy quality of life, especially
in relation to symptomatic outcome and psychological
predictors. Moreover, this study has the disadvantage that
we have two separate measures, at baseline and at
follow-up at 6 months. Therefore the study does not
differentiate between the persistence of symptoms and
the development of symptoms after initial disappearance
after cholecystectomy. Comparing findings shortly after
cholecystectomy (e.g. 6 weeks) with findings at 6 months
may convey the course of symptoms over time. Further-
more, in the current study we did not control for
confounding postoperative variables, such as comorbid
diseases and major life events. Therefore, results at
6 months may be influenced by other factors than the
recovery after cholecystectomy.
Implications
The results of the present study may have implications for
the management of symptomatic cholelithiasis. Surgeons
must be aware that less than half of their patients are
free of symptoms at 6 months after cholecystectomy.
Therefore, patients should be informed about the consid-
erable risk of persistent and developing symptoms at
6 months. Generally, cholecystectomy is used to prevent
further episodes of biliary colics and complications,
8 whereas
expectative management is often disregarded. The use of
ursodeoxycholic acids (in combination with lithotripsy)
remains a matter of debate.
34 If treated expectatively, the
risk of complications such as acute cholecystitis, acute
pancreatitis, or biliary duct obstruction is small (1–2% a
year)
35,36 and biliary pain recurs only in 31% of the patients
with previous biliary attacks >1 year.
37 Most interesting is
that the rate of complications, improvements of quality of
life, and reduced pain over a period of 5 years are equal for
expectative management and cholecystectomy. Starting
expectatively, only 23–49% of the patients underwent
cholecystectomy because of recurred pain and complications
within 2.5–5y e a r s .
25,38 As expectative management is safe
and offers good prospectives, it should be preferred as
treatment to start with in cholelithiasis especially in patients
with a high risk of postoperative symptoms.
Recognition of high-risk patients is crucial to gear the
treatment to the patient's characteristics. In patients with
classical biliary symptoms (alone or together with dyspeptic
symptoms), surgeons should be attentive to non-specific
symptoms during anamnesis. In patients using psychotropic
medication and patients reporting dyspeptic symptoms
only, wait-and-see should be considered as the treatment
of choice. Limiting our recommendations to the persistence
of biliary symptoms, which are most indicative of an
unsuccessful procedure, patients with HTA should be
informed about their heightened risk. Furthermore, in
HTA patients, the biliary or dyspeptic nature of preoperative
symptoms should be addressed carefully. Expectative man-
agementshouldbeconsideredespeciallyinHTApatientswith
dyspeptic symptoms or using psychotropic medication.
Alternatively,psychotherapeuticinterventionsstemmingfrom
cognitive behavioural therapy or mindfulness may teach
patients how to deal with anxiety provoking situations and
mayreducestressinHTApatients.Consequently,thenegative
influence of HTA may be reduced and postoperative
symptomatic outcomes may be improved. Summarised, in
cholelithiasis, surgeons should offer patients a treatment
which is based on individual risks and expectations. Hope-
fully, the rate of unsuccessful treatments will be reduced,
which will lead to greater cost-efficiency in health care.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and
ethnic differences in gallbladder disease in the United States.
Gastroenterology 1999;117:632–639.
2. Attili AF, Carulli N, Roda E, et al. Epidemiology of gallstone
disease in Italy: Prevalence data of the multicenter Italian study on
cholelithiasis (M.I.Col.) Am J Epidem 1995;141:158–165.
3. Aerts R, Penninckx F. The burden of gallstone disease in Europe.
Alim Pharmacol Ther 2003;18 Suppl 3:49–53.
4. SSAT patient care guidelines. Treatment of gallstone and
gallbladder disease. J Gastrointest Surg 2007;11:1222–1224.
5. Keus F, Broeders IA, van Laarhoven CJ. Gallstone disease: Surgical
aspects of symptomatic cholecystolithiasis and acute cholecystitis.
Best Pract Res Clin Gastroenterol 2006;20:1031–1051.
6. Jacoby I, Scott TE. NIH consensus conference on laparoscopic
cholecystectomy: Are reforms necessary. JAMA 1993;270:320–321.
7. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett
PM. Symptomatic and silent gall stones in the community. Gut
1991;32:316–320.
8. Ransohoff DF, Gracie WA. Treatment of gallstones. Ann Intern
Med 1993;119:606–619.
9. Lorusso D, Porcelli P, Pezzolla F, et al. Persistent dyspepsia after
laparoscopic cholecystectomy. The influence of psychological
factors. Scand J Gastroenterol 2003 38:653–658.
1278 J Gastrointest Surg (2010) 14:1271–127910. Luman W, Adams WH, Nixon SN, et al. Incidence of persistent
symptoms after laparoscopic cholecystectomy: A prospective
study. Gut 1996;39:863–866.
11. Mertens MC, De Vries J, Scholtes VP, Jansen P, Roukema JA.
Prospective 6 weeks follow-up post-cholecystectomy: The predic-
tive value of pre-operative symptoms. J Gastrointest Surg
2009;13:304–311.
12. Borly L, Anderson IB, Bardram L, et al. Preoperative prediction
model of outcome after cholecystectomy for symptomatic gall-
stones. Scand J Gastroenterol 1999;34:1144–1152.
13. Weinert CR, Arnett D, Jacobs D, Kane R. Relationship between
persistence of abdominal symptoms and successful outcome after
cholecystectomy. Arch Intern Med 2000;160:989–995.
14. Bisgaard T, Rosenberg J, Kehlet H. From acute to chronic pain
after laparoscopic cholecystectomy: A prospective follow-up
analysis. Scand J Gastroenterol 2005;40:1358–1364.
15. Lublin M, Crawford D, Hiatt JR, Phillips EH. Symptoms before
and after laparoscopic cholecystectomy for gallstones. Am Surg
2004;70:863–866.
16. Ure BM, Troidl H, Spangenberger W, et al. Pain after laparoscopic
cholecystectomy. Intensity and localization of pain and analysis of
predictors in preoperative symptoms and intraoperative events.
Surg Endosc 1994;8:90–96.
17. Scott LE, Clum GA, Peoples JB. Preoperative predictors of
postoperative pain. Pain 1983;15:283–293.
18. Bisgaard T, Klarskov B, Rosenberg J, Kehlet H. Characteristics
and prediction of early pain after laparoscopic cholecystectomy.
Pain 2001;90:261–269.
19. Levesque L, Grenier R, Kerouac S, Reidy M. Evaluation of a
presurgical group program given at two different times. Res Nurs
Health 1984;7:227–236.
20. Stefaniak T, Vingerhoets A, Babinska D, et al. Psychological
factors influencing results of cholecystectomy. Scand J Gastro-
enterol 2004;39:127–132.
21. Berger MY, Olde Hartman TC, van der Velden JJIM, Bohnen AM.
Is biliary pain exclusively related to gallbladder stones? A
controlled prospective study. Br J Gen Pract 2004;54:574–579.
22. Keus F, de Vries J, Gooszen HG, van Laarhoven CJ. Assessing
factors influencing return back to work after cholecystectomy: A
qualitative research. BMC Gastroenterol 2010;10:12.
23. Kane RL, Lurie N, Borbas C, et al. The outcomes of elective
laparoscopic and open cholecystectomies. J Am Coll Surg
1995;180:136–145.
24. van der Ploeg HM, Defares P, Spielberger CD. Handleiding bij de
zelf-beoordelingsvragenlijst ZBV. Een Nederlandse bewerking
van de Spielberger State-Trait Anxiety Inventory. Lisse, the
Netherlands, Swets and Zeitlinger BV, 1981.
25. Vetrhus M, Soreide O, Eide GE, et al. Pain and quality of life in
patients with symptomatic, non-complicated gallbladder stones:
Results of a randomized controlled trial. Scand J Gastroenterol
2004;39:270–276.
26. Abu Farsakh NA, Stietieh M, Abu Farsakh FA. The postchole-
cystectomy syndrome. A role for duodenogastric reflux. J Clin
Gastroenterol 1996;22:197–201.
27. Diehl AK. Symptoms of gallstone disease. Baillieres Clin
Gastroenterol 1992;6:635–657.
28. Taenzer P, Melzack R, Jeans ME. Influence of psychological
factors on postoperative pain, mood and analgesic requirements.
Pain 1986;24:331–342.
29. Spielberger CD. Manual for the State-Trait Anxiety Inventory
(STAI). Palo Alto: Consulting Psychologists Press, 1983.
30. Watson D, Pennebaker JW. Health complaints, stress, and distress:
Exploring the central role of negative affectivity. Psychol Rev
1989;96:234-254.
31. Addolorato G, Mirijello A, D'Angelo C, et al. State and trait
anxiety and depression in patients affected by gastrointestinal
diseases: Psychometric evaluation of 1641 patients referred to an
internal medicine outpatient setting. Int J Clin Pract
2008;62:1063–1069.
32. Narita K, Murata T, Hamada T, et al. Interactions among higher
trait anxiety, sympathetic activity, and endothelial function in the
elderly. J Psychiatr Res 2007;41:418–427.
33. Salmon P, Pearce S, Smith CC, et al. Anxiety, type A personality
and endocrine responses to surgery. Br J Clin Psychol 1989;28 (
Pt 3):279–280.
34. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the
treatment of cholesterol cholelithiasis. Part II. Dig Dis Sci
1982;27:833–856.
35. Friedman G, Raviola C, Fireman B. Prognosis of gallstones with
mild or no symptoms: 25years of follow-up in a health
maintenance organization. J Clin Epidem 1989;42:127–136.
36. Newman H, Northup J, Rosenbaum M, Abrams H. Complications
of cholelithiasis. Am J Gastroenterol 1968;50:476–496.
37. Thistle JL, Cleary PA, Lachin JM, Tyor MP, Hersh T. The natural
history of cholelithiasis: The national cooperative gallstone study.
Ann Intern Med 1984;101:171–175.
38. Sondenaa K, Nesvik I, Solhaug JH, Soreide O. Randomization to
surgery or observation in patients with symptomatic gallbladder
stone disease. The problem of evidence-based medicine in clinical
practice. Scand J Gastroenterol 1997;32:611–616.
J Gastrointest Surg (2010) 14:1271–1279 1279